Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for decreasing set in inhibiting protein phosphatase 2A (PP2A) and/or increasing the activity of cyclin-dependent kinase 5 (CDK5) by an APOE peptide

Methods for decreasing set in inhibiting protein phosphatase 2A (PP2A) and/or increasing the activity of cyclin-dependent kinase 5 (CDK5) by an APOE peptide

US Patent 9730979 · Granted Aug 15, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modified peptide fragments of Cav-1 protein and the use thereof in the treatment2025
Dry powder formulation of caveolin-1 peptides and methods of use thereof2025
Dry powder formulation of caveolin-1 peptides and methods of use thereof2025
Modified peptide fragments of CAV-1 protein and the use thereof in the treatment2024
Modified peptide fragments of CAV-1 protein and the use thereof in the treatment2023
Compounds and methods for the treatment of neurodegenerative diseases2022
Compounds and methods for the treatment of neurodegenerative diseases2019
Peptide inhibitors of sodium channels2018
ApoE peptide dimers and uses thereof2017
ApoE peptide dimers and uses thereof2017
ApoE peptide dimers and uses thereof2017
ApoE peptide dimers and uses thereof2017